Consistent Effect Not Achieved
Hopes to conquer malaria, related to the first vaccine developed by GlaxoSmithKline are broken. Consistent effect could not be achieved
Study results have shown that within the first year after vaccination the risk of malaria in children was 35.9 per cent less than in the reference group, while at the seven year time point the difference was just 4.4 per cent. This evidence has been published in the New England Journal of Medicine.
Although the vaccine is not perfect, it may leverage development of improved vaccines of new generation. GlaxoSmithKline is continuing to work in that direction.